The combination of PTP4A3 with immune cells is proposed as a predictor for immunotherapy response and prognosis in renal cancers, with potential applications in other cancer types such as NSCLC or gastric cancer as well (57, 58). The gene discussed is PTP4A3; the disease is renal carcinoma.